Table: begin end state 1 6 cytoplasmic 7 28 transmembrane 29 49 non-cytoplasmic 50 69 transmembrane 70 80 cytoplasmic 81 98 transmembrane 99 103 non-cytoplasmic 104 127 transmembrane 128 140 cytoplasmic 141 161 transmembrane 162 180 non-cytoplasmic 181 200 transmembrane 201 260 cytoplasmic 261 284 transmembrane 285 298 non-cytoplasmic 299 320 transmembrane 321 326 cytoplasmic 327 347 transmembrane 348 363 non-cytoplasmic 364 389 transmembrane 390 400 cytoplasmic 401 419 transmembrane 420 423 non-cytoplasmic 424 449 transmembrane 450 466 cytoplasmic
Input: >Ga0059261_1891 MNGESRANMGLIMAIVAVATIGGLLFGYDSGAVNGTQDGLKSAFALSEGGLGFTVGSLLI GCFIGAFLAGRLADLIGRRNVMILTAVLFLIGALIQGFSHEQWIFVAARIAGGMAVGAAS VLSPAYISEVAPANIRGRMTTIQQIMIISGLTAAFVVNYWLAKTAGASTNLFWGGYEAWR WMYWMQAIPATVFLIALFFIPESPRYLVSKGRNAEATRVLTSLFGAGTATNKLTEIQASF SDHRPTLRDILDPVKGGVRPIVWAGLLLAVFQQLVGINVIFYYGATLWQLAGFTENDALL INIVSGFVSIAACFVTVALVDRIGRKPLLLIGSAGMAVALFAMVFAFSRGSLDAQGKLVL SQQLGIIAVIAANLYVVFFNVSWGPVMWVMLGEMFPNQIRGSALAVCGFAQWFSNYLIAQ SFPIMAAGLGLAVSYSFYAVCAVISFFLVSKFIHETKGVELEDMQG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server